Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
05/1999
05/20/1999WO1999024465A1 Stabilized primate lentivirus envelope glycoproteins
05/20/1999WO1999024464A1 Glycosylated modified primate lentivirus envelope polypeptides
05/20/1999WO1999024463A2 Signal peptide-containing proteins
05/20/1999WO1999024462A2 Novel conjugates of rgd-containing peptides and endogenous carriers
05/20/1999WO1999024455A1 Detection systems for registering protein interactions and functional relationships
05/20/1999WO1999024453A1 Mammalian pro-apoptotic bok genes and their uses
05/20/1999WO1999024411A1 Receptor with an affinity for compounds of the oxazoline class
05/20/1999WO1999024107A1 Biodegradable, anionic polymers derived from the amino acid l-tyrosine
05/20/1999WO1999024076A2 Salicylate derivatized therapeutic and diagnostic agents
05/20/1999WO1999024075A2 Affinity markers for human serum albumin
05/20/1999WO1999024074A2 Novel conjugates of opioids and endogenous carriers
05/20/1999WO1999024069A1 Preventives and remedies for diffuse lung diseases
05/20/1999WO1999024068A1 Immortal avian cell line to grow avian and animal viruses to produce vaccines
05/20/1999WO1999024067A1 Micobacterium vaccae preparation comprising cold-shock proteins and its use in therapy
05/20/1999WO1999024062A1 Novel igf-i composition and its use
05/20/1999WO1999024058A2 Neuronal uses of bmp-11
05/20/1999WO1999024057A2 Neuronal uses of bmp-11
05/20/1999WO1999024055A1 Therapeutic molecules
05/20/1999WO1999024054A1 Host derived proteins binding hcv: medical, diagnostic and purification use
05/20/1999WO1999024052A2 Use of protein h as cytostatic agent
05/20/1999WO1999023885A1 Methods for the use of inhibitors of co-repressors for the treatment of neoplastic diseases
05/20/1999WO1999023880A1 Somatic transfer of modified genes to predict drug effects
05/20/1999WO1999023867A2 Bmog, a protein member of the myelin-oligodendrocyte glycoprotein family and its use
05/20/1999WO1999018213A8 MUTANTS OF YEAST Cdc24p, DEFECTIVE IN BINDING OF THE G-PROTEIN BETA SUBUNIT
05/20/1999WO1999016893A3 Enzymatic modification
05/20/1999WO1999016880A3 Protein involved in abscisic acid signalling
05/20/1999WO1999016791A3 Compounds and methods for regulating cell adhesion
05/20/1999WO1999015665A3 Mutants of thyroid stimulating hormone and methods based thereon
05/20/1999WO1999015653A3 Tie ligand homologues
05/20/1999WO1999015553A3 Costimulating t-cell polypeptide, monoclonal antibodies, their preparation and use
05/20/1999WO1999011666B1 N-terminal modifications of rantes and methods of use
05/20/1999WO1999010506A9 Mosaic protein and restriction endonuclease assisted ligation method for making the same
05/20/1999WO1999010475A3 Attenuated strains of mycobacteria
05/20/1999WO1999010369A9 Compositions, kits, and methods for effecting adenine nucleotide modulation of dna mismatch recognition proteins
05/20/1999WO1999010368A9 Presenilin-1 gene promoter
05/20/1999WO1999009167A8 Porcine mhc class i genes and uses thereof
05/20/1999WO1999007736A3 Lipoprotein-regulating medicaments
05/20/1999WO1999007734A3 Hepatitis c inhibitor peptide analogues
05/20/1999WO1999007733A3 Hepatitis c inhibitor peptides
05/20/1999WO1999006557A3 Mammalian cell membrane proteins; related reagents
05/20/1999WO1999006549B1 5' ESTs FOR SECRETED PROTEINS EXPRESSED IN TESTIS AND OTHER TISSUES
05/20/1999WO1999004007A9 Increasing production of proteins in gram-positive microorganisms
05/20/1999WO1998051788A3 Method and construct for inhibition of cell migration
05/20/1999WO1998031796A8 Novel ifn receptor 1 binding proteins, dna encoding them, and methods of modulating cellular response to interferons
05/20/1999WO1998013007A8 Methods and compositions for lipidization of hydrophilic molecules
05/20/1999DE19756678C1 Gene for murine odorant binding protein
05/20/1999DE19750220A1 Producing polyoma virus-like particles in yeast for gene therapy, vaccine development and diagnosis
05/20/1999DE19749277A1 Removing albumin from liquid by affinity chromatography, for purification of fluids or albulmin recovery
05/20/1999CA2671261A1 Neisserial antigens
05/20/1999CA2628053A1 Affinity markers for human serum albumin
05/20/1999CA2319380A1 Nucleic acid fragments and polypeptide fragments derived from m. tuberculosis
05/20/1999CA2310213A1 Novel reovirus-derived proteins, nucleic acids encoding same, and uses therefor
05/20/1999CA2309640A1 Nuclear targeting by means of bacterial proteins
05/20/1999CA2309603A1 Receptor with an affinity for compounds of the oxazoline class
05/20/1999CA2309598A1 Preventives and remedies for diffuse lung disease
05/20/1999CA2309559A1 Hp90: host membrane receptor for pathogenic bacteria, encoded by the bacterial tir gene
05/20/1999CA2309557A1 Tumor-specific antigens, methods for their production and their use for immunization and diagnosis
05/20/1999CA2309543A1 Methods and compositions for peptide libraries displayed on light-emitting scaffolds
05/20/1999CA2309538A1 Neuronal uses of bone morphogenetic protein -11
05/20/1999CA2309535A1 The translation enhancer element of the human amyloid precursor protein gene
05/20/1999CA2309383A1 Genes with restricted expression in mesencephalic dopaminergic neurons
05/20/1999CA2309360A1 Differentially expressed genes in cardiac hypertrophy and their uses in treatment and diagnosis
05/20/1999CA2309335A1 Igg-binding protein from staphylococcus and nucleotide sequence encoding this protein
05/20/1999CA2309323A1 Gene coding for thanatin, vector containing same and resulting transformed disease-resistant plants
05/20/1999CA2309317A1 Bovine milk growth factor
05/20/1999CA2309205A1 Novel conjugates of rgd-containing peptides and endogenous carriers
05/20/1999CA2309007A1 Secreted proteins and polynucleotides encoding them
05/20/1999CA2308779A1 Human blood bacterium
05/20/1999CA2308768A1 125 human secreted proteins
05/20/1999CA2308606A1 Neisserial antigens
05/20/1999CA2308440A1 Bmog, a protein member of the myelin-oligodendrocyte glycoprotein family and its use
05/20/1999CA2308377A1 Methods for the use of inhibitors of co-repressors for the treatment of neoplastic diseases
05/20/1999CA2306254A1 Detection and typing of the icea gene of helicobacter pylori
05/20/1999CA2305847A1 Multi-mer peptides derived from hepatitis c virus envelope proteins for diagnostic use and vaccination purposes
05/20/1999CA2305715A1 Host derived proteins binding hcv: medical, diagnostic and purification use
05/20/1999CA2276250A1 Ciita-interacting proteins and methods of use therefor
05/19/1999EP0916732A1 The engineering of electronic interactions at metal ion binding sites for the stabilization of proteins
05/19/1999EP0916727A2 Novel LysS
05/19/1999EP0916726A1 Attaching substances to micro-organisms
05/19/1999EP0916681A1 Neuropeptides originating in scorpion
05/19/1999EP0916680A2 Lantibiotic related to Actagardine, process of preparation and use thereof
05/19/1999EP0916677A1 Method for searching for peptides and process for producing compounds
05/19/1999EP0916647A2 Hydrophilic agent, process for producing it and his use as dispersing agent for aqueous polyurethane dispersions
05/19/1999EP0916396A2 Combinatorial strategies for polymer synthesis
05/19/1999EP0916352A2 Use of polymers to inhibit the denaturation of absorbed proteins
05/19/1999EP0916085A1 Phytofluors as fluorescent labels
05/19/1999EP0915989A1 Assays for protein kinases using fluorescent protein substrates
05/19/1999EP0915987A2 POLY-($g(a)-L-ASPARTIC ACID), POLY-($g(a)-L-GLUTAMIC ACID) AND COPOLYMERS OF L-ASP AND L-GLU, METHOD FOR THEIR PRODUCTION AND THEIR USE
05/19/1999EP0915984A1 Production of apomictic seed
05/19/1999EP0915981A1 Isolation of the biosynthesis genes for pseudo-oligosaccharides from streptomyces glaucescens gla.o and their use
05/19/1999EP0915980A2 Characterization of granulocytic ehrlichia and methods of use
05/19/1999EP0915979A2 Nucleic acids, proteins, and methods of use of granulocytic erhlichia
05/19/1999EP0915978A2 Dna immunization against chlamydia infection
05/19/1999EP0915977A1 B. burgdorferi polypeptides expressed in vivo
05/19/1999EP0915975A2 Methods for administration of recombinant gene delivery vehicles for treatment of hemophilia
05/19/1999EP0915974A1 Modified tie-2-receptor ligands
05/19/1999EP0915973A1 Gene involved in cadasil, method of diagnosis and therapeutic application
05/19/1999EP0915972A1 Mammalian deep orange proteins
05/19/1999EP0915971A2 Polynucleotides from human adult pbmc endocing secreted proteins
05/19/1999EP0915970A1 Type c lectins
1 ... 2282 2283 2284 2285 2286 2287 2288 2289 2290 2291 2292 2293 2294 2295 2296 2297 2298 2299 2300 2301 2302 ... 2916